Home About Us Pipeline News Investors Contacts Careers


News

Recent Press Releases Archives

Recent Press Releases

2017 News Releases

April 17, 2017 - Puma Biotechnology Announces FDA Advisory Committee to Review Neratinib for the Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer
Read

April 4, 2017 - Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial of PB272 in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer at the 2017 AACR Annual Meeting
Read

April 2, 2017 - Puma Biotechnology Presents Interim Results of Phase Ib/II FB-10 Trial of PB272 in Combination with Trastuzumab Emtansine (T-DM1) in HER2-Positive Metastatic Breast Cancer at the 2017 AACR Annual Meeting
Read

April 2, 2017 - Puma Biotechnology Presents Results from the Phase II SUMMIT Trial of PB272 for ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Cancer at the 2017 AACR Annual Meeting
Read

April 2, 2017 - Puma Biotechnology Launches Expanded Access Program for PB272 (Neratinib) for U.S. Patients with HER2-Positive Breast Cancer or HER2-Mutated Cancers
Caligor Opco LLC to Provide Regulatory and Logistical Management
Read

March 2, 2017 - Puma Biotechnology to Present at Cowen’s Health Care Conference
Read

March 1, 2017 - Puma Biotechnology Announces Publication of Abstracts on Neratinib for the AACR Annual Meeting 2017
Read

March 1, 2017 - Puma Biotechnology Provides Update on Review of Marketing Authorisation Application for PB272
Read

March 1, 2017 - Puma Biotechnology Reports Fourth Quarter and Full Year 2016 Financial Results
Read

February 14, 2017 - Puma Biotechnology to Present at RBC Capital Markets Healthcare Conference
Read

February 8, 2017 - Puma Biotechnology to Present at LEERINK Partners Global Healthcare Conference
Read

January 6, 2017 - Puma Biotechnology Expands Cohort in Phase II SUMMIT Trial of PB272 in HER2 Mutation-Positive Cancer Patients
Read

January 3, 2017 - Puma Biotechnology to Present at J.P. Morgan Healthcare Conference
Read




Corporate Fact Sheet

Puma Biotechnology, Inc.

10880 Wilshire Blvd., Suite 2150
Los Angeles, CA 90024
424-248-6500 Main
424-248-6501 Fax

info@pumabiotechnology.com